SAN DIEGO, Sept. 16, 2020 /PRNewswire/ -- Evofem
Biosciences, Inc. (NASDAQ: EVFM) today announced that its virtual
fireside chat at the 2020 Cantor Global Virtual Healthcare
Conference will take place from 1:20 p.m. to
1:50 p.m. ET on Thursday, September 17, 2020. This is an
adjustment from the previously announced date and time.
To access the live and archived webcast of this fireside chat,
visit the Investors section of the Evofem Biosciences website
at www.evofem.com, and select the Events and
Presentations tab.
About Evofem Biosciences, Inc.
Evofem Biosciences,
Inc., (NASDAQ: EVFM) is a commercial-stage biopharmaceutical
company committed to developing and commercializing innovative
products to address unmet needs in women's sexual and reproductive
health, including hormone-free, woman-controlled contraception and
protection from certain sexually transmitted infections (STIs). The
Company's first commercial product, Phexxi™ (lactic acid, citric
acid and potassium bitartrate), is the first and only hormone-free,
prescription vaginal gel approved in the United
States for the prevention of pregnancy. The Company is also
advancing EVO100 into a Phase 3 clinical trial for the prevention
of urogenital transmission of both Chlamydia
trachomatis and Neisseria gonorrhoeae in
women. For more information, please
visit www.evofem.com.
Phexxi™ is a trademark of Evofem Biosciences, Inc.
Investor Relations Contact
Amy
Raskopf
Evofem Biosciences, Inc.
araskopf@evofem.com
Office: (858) 550-1900 x167
Mobile: (917) 673-5775
View original
content:http://www.prnewswire.com/news-releases/evofem-biosciences-announces-updated-date-and-time-for-fireside-chat-at-cantor-global-virtual-healthcare-conference-301132488.html
SOURCE Evofem Biosciences, Inc.